Crohn Disease and Ulcerative Colitis

Immunology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Grifols
GrifolsNEW YORK, NY
1 program
Use of the test for treatment optimizationN/A1 trial
Active Trials
NCT06666569CompletedEst. May 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GrifolsUse of the test for treatment optimization

Clinical Trials (1)

NCT06666569GrifolsUse of the test for treatment optimization

Evaluation of the Effectiveness of Kits Promonitor-IFX/ADL and Promonitor-Anti-IFX/ADL in Patients With IBD

Start: Jan 2017Est. completion: May 2023
N/ACompleted

Related Jobs in Immunology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space